Ethnicity effect on the serum lipid profile in persons with spinal cord injury

Archives of Physical Medicine and Rehabilitation

Volumn 79, Issue 2, 1998, Pages 176-180

  Bauman, William A ^a,b,c   Adkins, Rodney H ^c   Spungen, Ann M ^a,b   Maloney, Patricia ^d   Gambino, Raymond ^d   Waters, Robert L ^c,e,f  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c RANCHO LOS AMIGOS NATIONAL REHABILITATION CENTER   (United States)

^d QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

^e LAC USC MEDICAL CENTER   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; ETHNIC GROUP; HUMAN; HYPERCHOLESTEROLEMIA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; PARAPLEGIA; QUADRIPLEGIA; RACE DIFFERENCE; SPINAL CORD INJURY;

EID: 0031905731     PISSN: 00039993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-9993(98)90296-9     Document Type: Article

References (34)

1. Whiteneck G. Learning from empirical investigations. In: Menter R, Whiteneck G, editors. Perspectives on aging with spinal cord injury. New York: Demos Publications; 1992. p. 23-37.
2. Geisler WO, Jousse AT, Wynne-Jones M, Breithaupt D. Survival in traumatic sinal cord injury. Paraplegia 1983;21:364-73.
3. Bauman WA, Zhong YG, Petty C, Gordon SK. Depressed serum high density lipoprotein cholesterol levels in veterans with spinal cord injury. Paraplegia 1992;30:697-703.
4. Brenes G, Dearwater S, Shapera R, LaPorte RE, Collins E. High density lipoprotein cholesterol concentrations in physically active and sedentary spinal cord injured patients. Arch Phys Med Rehabil 1986;67:445-50.
5. Dearwater SR, La Porte RE, Robertson RJ, Brenes G, Adams LL, Becker D. Activity in the spinal cord-injured patient: an epidemiologic analysis of metabolic parameters. Med Sci Sports Exerc 1986; 18:541-4.
6. Bauman WA, Adkins RH, Spungen AM, Waters RL. The effect of residual neurological deficit on serum lipoprotein profiles in persons with chronic spinal cord injury. Paraplegia. In press 1997.
7. Srinivasan SR, Powers CR, Webber LS, Berenson GS. Serum lipid and lipoprotein profiles of military personnel and their families: Fort Polk Heart Smart Program. Mil Med 1993;158:323-6.
8. Rubins HB, Robins SJ, Collins D, Iranmanesh A, Wilt TJ, Mann D, et al. Distribution of lipids in 8,500 men with coronary artery disease. Department of Veterans Affairs HDL Intervention Trial Study Group. Am J Cardiol 1995;75:1196-1201.
9. Sprafka JM, Norsted SW, Folsom AR, Burke, GL, Luepker RV. Life-style factors do not explain racial differences in high-density lipoprotein cholesterol: the Minnesota Heart Survey. Epidemiology 1992;3:156-63.
10. Brown SA, Hutchinson R, Morrisett J, Boerwinkle E, Davis CE, Gotto AM, et al. Plasma lipid, lipoprotein cholesterol, and apoprotein distributions in selected US communities. The Atherosclerosis Risk in Communities (ARIC) study. Arterioscler Thromb 193;13: 1139-58.
11. Freedman DS, Strogatz DS, Williamson DF, Aubert RE. Education, race, and high-density lipoprotein cholesterol among US adults. Am J Public Health 1992;82:999-1006.
12. Goldbour U, Medalie JH. High density lipoprotein cholesterol and incidence of coronary heart disease: The Israeli Ischemic Heart Disease Study. Am J Epidemiol 1979;109:296-308.
13. Castelli WP. Epidemiology of coronary heart disease: The Framingham Study. Am J Med 1984;76:4-12.
14. Miles LA, Fless GM, Levin EG, Scanu AM, Plow EF. A potential basis for the thrombotic risks associated with lipoprotein(a). Nature 1989;332:301-3.
15. Loscalzo J, Weinfeld M, Fless G, Scanu AM. Lipoprotein (a) fibrin binding, and plasminogen activation. Arteriosclerosis 1990;10:240-5.
16. Scott J. Lipoprotein(a). Thrombotic and atherogenic. BMJ 1991; 303:663-4.
17. Scanu AM. Lp(a) as a marker for coronary heart disease risk. Clin Cardiol 1991;14:I-35-I-39.
18. Sorrentino MJ, Vielhauer C, Eisenbart JD, Fless GM, Scanu AM, Feldman T. Plasma lipoprotein(a) protein concentration and coronary artery disease in black patients compared with white patients. Am J Med 1992;93:658-62.
19. Scanu AM, Lawn RM, Berg K. Lipoprotein(a) and atherosclerosis. Ann Intern Med 1991;115:209-18.
20. Rader DJ, Brewer HB Jr. Lipoprotein(a). Clinical approach to a unique atherogenic lipoprotein. JAMA 1992;367:1109-12.
21. Heyden S, Von Eckardstein A, Schulte H, Schneider K, Assmann G. Raised lipoprotein(a) in hypercholesterolaemic black students compared to age-matched whites in North and South Carolina. Int J Epidemiol 1994;23:301-6.
22. Schreiner PJ. Lipoprotein(a) as a risk factor for preclinical atherosclerotic disease in a biracial cohort: The Atherosclerosis Risk in Communities (ARIC) Study. Chem Phys Lipids 1994;67/68:405-10.
23. Bovet P, Rickenbach M, Wietlisbach V, Riesen W, Shamlaye C, Darioli R, et al. Comparison of serum lipoprotein(a) distribution and its correlates among black and white populations. Int J Epidemiol 1994;23:20-7.
24. Cobbaert C, Kestleloot H. Serum lipoprotein(a) levels in racially different populations. Am J Epidemiol 1992;136:441-9.
25. Mankowitz K, Seip RL, Semenkovicj CF, Schonfeld G. Exercise detraining elevates Lp(a) levels [abstract]. Clin Res 1991;39:262A.
26. Holme I, Urdal P, Anderssen S, Hjermann I. Exercise-induced increase in lipoprotein(a). Atherosclerosis. 1996;122:97-104.
27. MacAuley D, McCrum EE, Stott G, Evans AE, Duly E, Trinick T, et al. Physical activity, lipids, apolipoproteins, and Lp(a) in Northern Ireland Health and Activity Survey. Med Sci Sports Exerc 1996; 28:720-36.
28. Hubinger L, Mackinnon LT. The effect of endurance training on lipoprotein (a) [Lp(a)] levels in middle-aged males. Med Sci Sports Exerc. 1996;28:757-64.
29. Israel RG, Sullivan MJ, Marks RH, Cayton RS, Chenier, TC. Relationship between cardiorespiratory fitness and lipoprotein(a) in men and women. Med Sci Sports Exerc 1994;26:425-31.
30. American Spinal Injury Association. Standards for neurological and functional classification of spinal cord injury. Chicago: American Spinal Injury Association; 1992.
31. Friedewald WT, Levy RI, Fredrickson DS. Estimation of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-508.
32. Lijoi E, Vecchio C. Evaluation of the nepholometric method for the determination of Lp(a) [abstract]. J Clin Chem 1991;37:64A.
33. Anderson RA, Burns TL, Wallace RB, Folsom AR, Sprafka JM. Genetic markers associated with high density lipoprotein cholesterol levels in a biracial population study. Genet Epidemiol 1992;9:109-21.
34. Stampfer MJ, Sacks FM, Salvini S, Willett WC, Hennekens CH. A prospective study of cholesterol, apolipoprotein values and the risk of myocardial infarction. N Engl J Med 1991;325:373-81.